27th Dec 2007 10:21
Allergy Therapeutics PLC27 December 2007 Provisional Grant of Options Allergy Therapeutics plc ("the Company") announces that pursuant to the AllergyTherapeutics plc Long Term Share Incentive Plan ("LTIP"), on 20 December 2007,provisional shares of 0.1 pence each in the share capital of the Company wereawarded to Keith Carter (Chief Executive Officer), Ian Postlethwaite (FinanceDirector), Christian Gratz (Executive Director), Tom Holdich (ExecutiveDirector), Ray Keeling, Kevin Wilkinson and Manjit Rahelu (senior operationalmanagers) at nil cost, as follows: Director/PDMR Number of Date from which Expiry date Total provisional exercisable provisional shares awarded shares held under LTIP Keith Carter 345,156 20 December 2010 20 December 2017 687,656Ian Postlethwaite 169,691 20 December 2010 20 December 2017 394,691Christian Gratz 198,320 20 December 2010 20 December 2017 423,320Tom Holdich 176,805 20 December 2010 20 December 2017 401,805Ray Keeling 151,330 20 December 2010 20 December 2017 245,761Kevin Wilkinson 147,870 20 December 2010 20 December 2017 187,870Manjit Rahelu 127,438 20 December 2010 20 December 2017 221,869 Distribution of ordinary shares of 0.1 pence each under the LTIP is conditionalon the Company's performance over the course of the next three years. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Allergy Thera.